Evaluation of glucose-lowering medications in older people: a comprehensive systematic review and network meta-analysis of randomized controlled trials.
老年人降糖藥物的評估:隨機對照試驗的綜合系統評價與網絡Meta分析。
Age Ageing 2024-08-13
Optimizing kidney and cardiovascular protection in an era of multiple effective treatments.
在多種有效治療時代中優化腎臟和心血管保護。
Curr Opin Nephrol Hypertens 2024-08-13
Detecting heart stress using NT-proBNP in patients with type 2 diabetes mellitus and hypertension or high-normal blood pressure: a cross-sectional multicentric study.
使用 NT-proBNP 偵測患有 2 型糖尿病及高血壓或高正常血壓患者的心臟壓力:一項橫斷面多中心研究。
Cardiovasc Diabetol 2024-08-12
Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis.
代謝性減重手術後體重回升或減重不足患者使用胰高血糖素樣肽-1 (GLP-1) 受體激動劑的安全性與療效:系統性回顧與統合分析。
Obes Rev 2024-08-12
GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes.
GLP-1RA 與 DPP-4i 在 2 型糖尿病中使用及高鉀血症與 RAS 阻斷劑停用的比率。
JAMA Intern Med 2024-08-12
Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes.
Tirzepatide 或 GLP-1 受體激動劑在 2 型糖尿病患者中的臨床結果。
JAMA Netw Open 2024-08-12